Literature DB >> 26860515

Blood glucose fluctuation accelerates renal injury involved to inhibit the AKT signaling pathway in diabetic rats.

Changjiang Ying1,2, Xiaoyan Zhou3, Zhenzhen Chang2, Hongwei Ling2, Xingbo Cheng4, Wei Li5.   

Abstract

Blood glucose fluctuation is associated with diabetic nephropathy. However, the mechanism by which blood glucose fluctuation accelerates renal injury is not fully understood. The aim of the present study was to assess the effects of blood glucose fluctuation on diabetic nephropathy in rats and investigate its underlying mechanism. Diabetes in the rats was induced by a high sugar, high-fat diet, and a single dose of STZ (35 mg/kg)-injected intraperitoneally. Unstable blood sugar models were induced by subcutaneous insulin injection and intravenous glucose injection alternately. Body weight, glycosylated hemoglobin A1c (HbAlc), blood urea nitrogen (BUN), serum creatinine (Scr), and Creatinine clearance (Ccr) were assessed. T-SOD activity and MDA level were measured by assay kit. Change in renal tissue ultrastructure was observed by light microscopy and electron microscopy. Phosphorylated ser/thr protein kinase (p-AKT) (phosphor-Ser473), phosphorylated glycogen synthase kinase-3 beta (p-GSK-3β) (phosphor-Ser9), Bcl-2-associated X protein (BAX), B cell lymphoma/leukemia 2 (BCL-2), and cleaved-cysteinyl aspartate-specific proteinase-3 (caspase-3) levels were detected by immunohistochemistry and Western blot. We observed that BUN and Scr were increased in diabetic rats, and Ccr was decreased. Furthermore, blood glucose fluctuations could exacerbate the Ccr changes. Renal tissue ultrastructure was also seriously injured by glucose variability in diabetic rats. In addition, glucose fluctuation increased the oxidative stress of renal tissue. Moreover, fluctuating blood glucose decreased p-AKT level and BCL-2, and increased p-GSK-3β, BAX, cleaved-caspase-3 levels, and ratio of BAX/BCL-2 in the kidneys of diabetic rats. In conclusion, these results suggest that blood glucose fluctuation accelerated renal injury is due, at least in part to its oxidative stress promoting and inhibiting the AKT signaling pathway in diabetic rats.

Entities:  

Keywords:  Blood glucose fluctuation; Cleaved-caspase-3; Diabetic nephropathy; p-AKT

Mesh:

Substances:

Year:  2016        PMID: 26860515     DOI: 10.1007/s12020-016-0867-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  59 in total

1.  Estimation of podocyte number: a comparison of methods.

Authors:  Kathryn Elizabeth White; Rudolf William Bilous
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

2.  Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death.

Authors:  T Tejada; P Catanuto; A Ijaz; J V Santos; X Xia; P Sanchez; N Sanabria; O Lenz; S J Elliot; A Fornoni
Journal:  Kidney Int       Date:  2008-04-02       Impact factor: 10.612

3.  Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.

Authors:  Vivian Soetikno; Kenichi Watanabe; Flori R Sari; Meilei Harima; Rajarajan A Thandavarayan; Punniyakoti T Veeraveedu; Wawaimuli Arozal; Vijayakumar Sukumaran; Arun Prasath Lakshmanan; Somasundaram Arumugam; Kenji Suzuki
Journal:  Mol Nutr Food Res       Date:  2011-08-30       Impact factor: 5.914

4.  The influence of self-monitoring blood glucose frequency on the oscillation of hemoglobin A1c and chronic complications.

Authors:  I-Chin Huang; Pei-Wen Wang; Rue-Tsuan Liu; Shih-Chen Tung; Jung-Fu Chen; Ming-Chun Kuo; Ching-Jung Hsieh
Journal:  Chang Gung Med J       Date:  2012 Jan-Feb

5.  Kidney involvement in a nongenetic rat model of type 2 diabetes.

Authors:  Ratna S Danda; Nusrath M Habiba; Hernan Rincon-Choles; Basant K Bhandari; Jeffrey L Barnes; Hanna E Abboud; Pablo E Pergola
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

6.  Development of glomerular lesions in experimental long-term diabetes in the rat.

Authors:  K Hirose; R Osterby; M Nozawa; H J Gundersen
Journal:  Kidney Int       Date:  1982-05       Impact factor: 10.612

7.  Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats.

Authors:  Shotaro Saito; Yasushi Teshima; Akira Fukui; Hidekazu Kondo; Satoru Nishio; Mikiko Nakagawa; Tetsunori Saikawa; Naohiko Takahashi
Journal:  Cardiovasc Res       Date:  2014-07-31       Impact factor: 10.787

8.  Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy.

Authors:  Madhavi J Rane; Ye Song; Shunying Jin; Michelle T Barati; Rui Wu; Hina Kausar; Yi Tan; Yuehui Wang; Guihua Zhou; Jon B Klein; Xiaokun Li; Lu Cai
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-02

9.  Ginsenoside Rb1 relieves glucose fluctuation-induced oxidative stress and apoptosis in Schwann cells.

Authors:  Bing Xue; Lianqing Sun; Xiaojin Li; Xuan Wang; Ying Zhang; Yiming Mu; Linlang Liang
Journal:  Neural Regen Res       Date:  2012-10-25       Impact factor: 5.135

10.  The cytotoxic role of intermittent high glucose on apoptosis and cell viability in pancreatic beta cells.

Authors:  Zhen Zhang; Jing Li; Lei Yang; Rongping Chen; Rui Yang; Hua Zhang; Dehong Cai; Hong Chen
Journal:  J Diabetes Res       Date:  2014-03-17       Impact factor: 4.011

View more
  13 in total

1.  Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy.

Authors:  Yurui Duan; Qingyang Luo; Yun Wang; Yali Ma; Fang Chen; Xiaoguang Zhu; Jun Shi
Journal:  J Biol Chem       Date:  2020-06-24       Impact factor: 5.157

Review 2.  Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data.

Authors:  Annunziata Nusca; Francesco Piccirillo; Federico Bernardini; Aurelio De Filippis; Federica Coletti; Fabio Mangiacapra; Elisabetta Ricottini; Rosetta Melfi; Paolo Gallo; Valeria Cammalleri; Nicola Napoli; Gian Paolo Ussia; Francesco Grigioni
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

3.  Inhibition of SGLT1 Alleviates the Glycemic Variability-Induced Cardiac Fibrosis via Inhibition of Activation of Macrophage and Cardiac Fibroblasts.

Authors:  Weihua Wu; Qian Chai; Ziying Zhang
Journal:  Mol Cell Biol       Date:  2021-11-29       Impact factor: 5.069

Review 4.  Risk factors for unstable blood glucose level: integrative review of the risk factors related to the nursing diagnosis.

Authors:  Andressa Magalhães Teixeira; Rosangela Tsukamoto; Camila Takáo Lopes; Rita de Cassia Gengo E Silva
Journal:  Rev Lat Am Enfermagem       Date:  2017-06-05

5.  Glucose fluctuation increased mesangial cell apoptosis related to AKT signal pathway.

Authors:  Changjiang Ying; Shanshan Wang; Yan Lu; Lei Chen; Yizhen Mao; Hongwei Ling; Xingbo Cheng; Xiaoyan Zhou
Journal:  Arch Med Sci       Date:  2019-04-30       Impact factor: 3.318

Review 6.  Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports.

Authors:  Nandu Thalange; Torben Biester; Thomas Danne
Journal:  Diabetes Ther       Date:  2019-06-11       Impact factor: 2.945

7.  The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes.

Authors:  Chia-Lin Lee; Cheng-Hsu Chen; Ming-Ju Wu; Shang-Feng Tsai
Journal:  Ther Adv Chronic Dis       Date:  2020-03-03       Impact factor: 5.091

Review 8.  Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications.

Authors:  Zhen-Ye Zhang; Ling-Feng Miao; Ling-Ling Qian; Ning Wang; Miao-Miao Qi; Yu-Min Zhang; Shi-Peng Dang; Ying Wu; Ru-Xing Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

9.  High Glucose Exacerbates TNF-α-Induced Proliferative Inhibition in Human Periodontal Ligament Stem Cells through Upregulation and Activation of TNF Receptor 1.

Authors:  Wenjun Zhu; Qihong Qiu; Haoyuan Luo; Fuping Zhang; Juan Wu; Xiaorui Zhu; Min Liang
Journal:  Stem Cells Int       Date:  2020-02-05       Impact factor: 5.443

10.  Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway.

Authors:  Yusong Nie; Chengxiao Fu; Huimin Zhang; Min Zhang; Hui Xie; Xiaopei Tong; Yao Li; Zhenyan Hou; Xinrong Fan; Miao Yan
Journal:  BMC Complement Med Ther       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.